ImmunoPrecise Antibodies Ltd. financial data

Symbol
IPA on Nasdaq
Location
Industrious, 823 Congress Ave, Suite 300, Austin, TX
Fiscal year end
April 30
Latest financial report
6-K - Q4 2023 - Mar 14, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 25.1M shares +2.34%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 1M CAD -36%
General and Administrative Expense 4.18M CAD +1.61%

Balance Sheet

Label TTM Value / Value Unit Change %
Goodwill 18.7M CAD
Assets 78.7M CAD
Liabilities 28.9M CAD